baber/WOPTO huggingface dataset:
Patent DE-69913655-T2 (DE)
Inventor: DUNCAN JAMES
IPC: B63H1/14
Filed: 1999-02-05
Granted: 2004-10-07
Abstract: A propulsion system for a water craft having at least one shaft extending rearwardly form the transom of the hull of the craft and a drive system for driving the at least one shaft. A surface piercing propeller is mounted on the at least one shaft, proximal to the trailing edge of the hull, so that the propeller operates in a transom cavity created behind the hull, in use of the craft. The ratio (S/C) of the spacing of the blades to the blade cord for each propeller is at least 2.0 along substantially the whole length of the blades. The propulsion system has a high operational efficiency particularly suited for high speed marine craft.
Patent DE-69917758-T2 (DE)
Inventor: HSU WILLIAM
IPC: A61N1/362
Filed: 1999-03-19
Granted: 2005-07-07
Abstract: A system for defibrillating an atrial region of a heart experiencing a supraventricular arrhythmia. The defibrillation system senses and analyzes both atrial and ventricular cardiac signals of the heart to determine if the heart is experiencing a supraventricular arrhythmia. Upon detecting a supraventricular arrhythmia, the defibrillation system begins delivering a train of atrial pacing pulses to the atria of the heart and a series of ventricular pacing pulses to the ventricles of the heart to synchronize the contractions of the heart with the pacing pulses. The defibrillation system then delivers a defibrillation electrical energy pulse across the atrial region at a predetermined coupling interval time after delivering a final atrial pacing pulse and a final ventricular pacing pulse so that the defibrillation pulse will fall outside the occurrence of a T-wave of the heart, thus reducing the likelihood of inducing ventricular fibrillation.
Patent DE-69919903-T2 (DE)
Inventor: PERTHU MICHAEL
IPC: A61M5/32
Filed: 1999-12-08
Granted: 2005-09-15
Abstract: An injection device (1) has a slide (3) which can be displaced in relation to a housing (2) from a retracted position to an injection position, and which comprises a portion (8) situated within the housing (2) and a portion (6) situated outside the housing, both portions (6, 8) being interconnected through a groove (10) in the housing (2). The portion (6) situated outside the housing (2) has a syringe holder (5) for securing a hypodermic syringe (4), and the slide (3) is pretensioned toward the injection position. The housing (2) at the groove (10) is constituted by a tube part, the outer and/or inner surface (7, 9) of which forms a guide for the slide (3), and the slide (3) has one or more contact faces which are in contact with the guide at least at three areas distributed over more than the half of the circumference of the tube part.
Patent DE-69920048-T2 (DE)
Inventor: KARUBE ISAO
IPC: G01N33/543
Filed: 1999-01-12
Granted: 2005-09-22
Abstract: A sensor chip for surface plasmon resonance which has a thin metal film, an antibody against a substance with the steroid skeleton such as a steroid hormone, a sex hormone or an environmental hormone (excluding triazine compounds), and a fixation layer for fixing the antibody to the thin metal film; and a method for detecting an environmental hormone which involves the step of exposing the antibody in the above-mentioned sensor chip to a sample, the step of irradiating the thin metal film with light and the step of determining the intensity of the light reflected by the thin metal film. This method achieves a high sensitivity and an excellent selectivity. <IMAGE>
Patent DE-69921380-T2 (DE)
Inventor: RAKOS RONALD
IPC: A61F2/00
Filed: 1999-02-24
Granted: 2005-11-10
Abstract: What is described herein is a endovascular tube or bifurcated prosthesis used for the repair of aneurysms or other vessel disease. This can be soft or hard occlusive disease. This prosthesis is constructed by fabricating a structure that consists of a textile or other polymeric material and through which is threaded a superelastic metal wire such as a nitinol, a ductile wire or other filament material. The textile can be a polymeric material. The wire provides the self-expandability of the current device. Ideally, the thickness of the device should be minimized, so that it can be delivered to the diseased site using a percutaneous procedure. <IMAGE>
Patent DE-69922108-T2 (DE)
Inventor: NAKATANI JIRO
IPC: C07C17/358
Filed: 1999-09-09
Granted: 2005-12-15
Abstract: Aromatic compounds having an alkyl group with at least 3 carbon atoms are produced in a process comprising at least one of the following steps:   (1) a step of contacting a starting material that contains an aromatic compound having a branched alkyl group with at least 3 carbon atoms, with a zeolite-containing catalyst in a liquid phase in the presence of hydrogen therein, thereby changing the position of the carbon atoms of the alkyl group bonding to the aromatic ring of the compound; (2) a step of contacting a starting material that contains an aromatic compound having a branched alkyl group with at least 3 carbon atoms, with a catalyst containing zeolite and containing rhenium and/or silver, in a liquid phase, thereby changing the position of the carbon atoms of the alkyl group bonding to the aromatic ring of the compound; (3) a step of contacting a halogenated aromatic compound having an alkyl group with at least 3 carbon atoms, with an acid-type catalyst, thereby isomerizing the compound; and (4) a step of treating a mixture of isomers of an aromatic compound having an alkyl group with at least 3 carbon atoms, with a zeolite adsorbent that contains at least one exchangable cation selected from alkali metals, alkaline earth metals, lead, thallium and silver, thereby separating a specific isomer from the isomer mixture through adsorption.
Patent DE-69924839-T2 (DE)
Inventor: LAGRANGE ALAIN
IPC: A61K8/49
Filed: 1999-12-22
Granted: 2006-01-12
Abstract: The present invention relates to the use, for dyeing keratin fibers, of at least one aliphatic cationic amine and of at least one compound chosen from an aldehyde, a ketone, a quinone and a diiminoisoindoline or 3-aminoisoindolone derivative, in order to obtain, by reaction without an oxidizing agent, a coloration of the said keratin fibers. The invention also relates to dye compositions comprising these compounds and to dyeing agents for using them.
Patent DE-69924872-T2 (DE)
Inventor: GAFRI OREN
IPC: B21D26/14
Filed: 1999-06-14
Granted: 2006-09-28
Abstract: A method and apparatus for inducing a physical change in at least one metal workpiece are provided. Energy is applied to at least a portion of the metal workpiece, the energy being a combination of energies of at least two distinct sources. One of these energies is a pulsed magnetic force (PMF) energy which induces a rapid movement in a portion of the metal workpiece. The second energy is one which acts synergistically with the first energy to impart the desired physical change.
Patent DE-69928625-T2 (DE)
Inventor: HOLTERMANN HENRI
IPC: A61F5/445
Filed: 1999-09-23
Granted: 2006-08-17
Abstract: The bag contains a filter (30) in the form of a flat strip with the two ends of its deodorising core (31), e.g. of activated carbon, exposed to the air or enclosed in the bag. The filter is held in place in the bag by diagonal welds (24,25) joining the bag walls and extending from the lateral edges (14,15) of the bag towards its upper edge (13). One of the welds stops short of the upper edge to form a channel (26) for gas to pass through to reach one end of the filter, while the bag has an outlet hoel (36) adjacent to the other end.
Patent HU-E030688-T2 (HU)
Title: Sample region merging
Inventor: HELLE PHILIPP
IPC: H04N19/52
Filed: 2011-04-13
Abstract: A favorable merging or grouping of simply connected regions into which the array of information samples is sub-divided, is coded with a reduced amount of data. To this end, a predetermined relative locational relationship is defined enabling an identifying, for a predetermined simply connected region, of simply connected regions within the plurality of simply connected regions which have the predetermined relative locational relationship to the predetermined simply connected region. Namely, if the number is zero, a merge indicator for the predetermined simply connected region may be absent within the data stream. In other embodiments, spatial sub-division is performed depending on a first subset of syntax elements, followed by combining spatially neighboring simply connected regions depending on a second subset of syntax elements, to obtain an intermediate sub-division.
Patent TR-200000620-T2 (TR)
Title: 6.9-Köprülü eritromisin türevleri.
Inventor: OR YAT SUN
IPC: A61P31/04
Filed: 1998-09-01
Abstract: Antibakteriyel tesir gösteren formül (I), (II) ve (III) haiz çok halkali yeni eritromisin bilesikleri ile bunlarin farmasötik açidan geçerli tuzlari ve esterleri, farmasötik açidan geçerli bir tasiyici madde ile bir arada bulusun önerdigi bilesigi sagaltim açisindan tesirli miktarda içeren bilesimler ve ayni zamanda bulusun önerdigi bilesigi sagaltim açisindan tesirli miktarda içeren bir farmasötik bilesimin bir memeliye verilmesi suretiyle bakteri enfeksiyonlarinin tedavisi için bir yöntem anlatilmaktadir.
Patent TR-200100854-T2 (TR)
Inventor: WALTER RAINER
IPC: C07D401/14
Filed: 1999-09-22
Abstract: The present invention relates to new substituted indolinones of general formulawhereinX and R1 to R5 are defined as in claim 1, the isomers and the salts thereof which have valuable properties.The above compounds of general formula I wherein R1 denotes a hydrogen atom, a C1-3-alkyl group or a prodrug group have valuable pharmacological properties, particularly an inhibiting effect on various kinases, on viral cyclin and on receptor tyrosine kinases, and the other compounds of the above general formula I wherein R1 does not represent a hydrogen atom, a C1-3-alkyl group or a prodrug group are valuable intermediate products for the preparation of the abovementioned compounds.
Patent TR-200103453-T2 (TR)
Title: Cinsiyet steroidi öncüleri ile kombinasyon halindeki bir selektif östrojen reseptör modülatörünün tıbbi kullanımları
Inventor: LABRIE FERNAND
IPC: A61K31/4453
Filed: 1999-06-10
Abstract: Dehidroepiandrosteron dehidroepiandrosteron sülfat, androst-5-en-3beta, 17beta-diol ve kendisinden birine in vivo olarak dönüstürülen bilesiklerden olusan gruptan seçilen bir cinsiyet steroidi öncünün bir miktari ve selektif östrojen reseptör modülatörü, bilhassa, genel yapi (1)' e sahip olan bilesiklerin verilmesini içeren, insanlar da dahil olmak üzere, hassas sicak kanlihayvanlardaki arteryoskleroz, hiperlipidemi, hiperkolesterplemi, gögüs kanseri veya osteoporozun tibbi tedavisi ve/veya bunlarin gelisiminin inhibisyonu için yeni metotlar. Selektif östrojen reseptör modülatörleri ve/veya cinsiyet steroidi öncüsü ile kombinasyon halindeki bifosfonatlarin ilave olarak verilmesi; osteoporozun tibbi tedavisi ve/veya bunun gelisiminin inhibasyonu için bildirilmektedir. Bulusa faydali aktif muhteviyat ve kitlerin dagitilmasi için farmasötik kompozisyonlar da bildirilmektedir.
Patent DE-602004005820-T2 (DE)
Inventor: NOLAN JOHN MATTHEW
IPC: G06F15/80
Filed: 2004-01-26
Granted: 2008-01-10
Abstract: There is disclosed a processor array, which achieves an approximately constant latency. Communications to and from the farthest array elements are suitably pipelined for the distance, while communications to and from closer array elements are deliberately "over-pipelined" such that the latency to all end-point elements is the same number of clock cycles. The processor array has a plurality of primary buses, each connected to a primary bus driver, and each having a respective plurality of primary bus nodes thereon; respective pluralities of secondary buses, connected to said primary bus nodes; a plurality of processor elements, each connected to one of the secondary buses; and delay elements associated with the primary bus nodes, for delaying communications with processor elements connected to different ones of the secondary buses by different amounts, in order to achieve a degree of synchronization between operation of said processor elements.
Patent DE-602004007338-T2 (DE)
Inventor: PERON PASCAL
IPC: B60K11/08
Filed: 2004-09-10
Granted: 2008-03-06
Abstract: The device has a movable unit with a flap (3) whose one pivoting end has a sprocket wheel (7) to control the pivoting of the flap. The wheel is coupled to a cylindrical axis of the end of the flap mounted in rotation in the corresponding pole (5). An endless screw permits the driving of the wheel to bring the flap to releasing position or closing position of an air flow passage opening. An independent claim is also included for a motor vehicle including an air flow adjusting device.
Patent DE-602004008488-T2 (DE)
Inventor: STENLAND CHRISTOPHER J
IPC: C07K1/22
Filed: 2004-09-07
Granted: 2008-01-03
Abstract: A method of preparing a solution containing biological material by adding a fumed metal oxide and/or particulate silicon dioxide to biological material to obtain a mixture of fumed metal oxide and/or particulate silicon dioxide and the biological material; and separating the fumed metal oxide and/or particulate silicon dioxide from the mixture to form a resulting solution, wherein any pathogenic prion proteins possibly contaminating the biological material are substantially reduced in the resulting solution.
Patent DE-602005001319-T2 (DE)
Inventor: LANIER RONALD A
IPC: B65D83/08
Filed: 2005-01-25
Granted: 2008-01-31
Abstract: A container is provided for dispensing selected portions of a web material retained on a roll. The container includes a substantially hollow dispenser tube, a track-guided cutting assembly and end caps securing the dispenser and track structure. The dispenser has an elongated opening in a portion of the side wall thereof. The end caps include a groove substantially corresponding to the profile shape of the dispenser, a projection substantially corresponding to the inner diameter of the roll, and a cutter track holder to secure the cutting assembly adjacent the opening in the dispenser.
Patent DE-69505171-T3 (DE)
Inventor: FERRARI FRANCO
IPC: A47B88/04
Filed: 1995-03-28
Granted: 2007-12-27
Abstract: A machine for fitting metal runners on a drawer comprises means (44) for mechanically operating at least one hammer (24) for clinching, against a side panel (16) of a drawer, gripping tabs (60) protruding from the metal runner (12) applied thereto. The hammer (24) and the corresponding anvil counter plate (22) extend in a longitudinal direction to the runner (12) to simultaneously clinch all the gripping tabs (60), said tabs protruding laterally, prior to clinching, from the runner towards the hammer, along a longitudinal edge of the runner. Advantageously, the machine comprises two clinching assemblies (20) to clinch both runners of a drawer in a single operation. <IMAGE>
Patent DK-1172274-T3 (DK)
Inventor: ELLENBERGER PETER
IPC: B61L3/12
Filed: 2000-07-12
Granted: 2006-08-14
Abstract: The transmission device allows a condition signal (ZS) for a railway signaling light (S) to be transmitted to a locomotive (L) via a transmission unit (TU) connected in a circuit loop with the setting circuit (RS) for the railway signaling light, with voltage pulses (SP) provided in a periodic sequence across the setting circuit contacts.
Patent DK-1244643-T3 (DK)
Inventor: BAER THOMAS
IPC: A61P11/06
Filed: 2000-12-16
Granted: 2004-10-18
Abstract: Compounds of the formula (I), in which M, A1, A2, K1 and K2 have the meanings indicated in the description are novel active tryptase inhibitors.
Patent DK-1326630-T3 (DK)
Inventor: HENRIKSEN DENNIS BANG
IPC: A61K39/00
Filed: 2001-09-17
Granted: 2008-09-15
Abstract: Glucagon-like peptide-2, its analogues and derivatives, for use in the treatment of hyperparathyroidism.
Patent DK-1349549-T3 (DK)
Inventor: PAIRET MICHEL
IPC: A61K31/56
Filed: 2001-12-12
Granted: 2010-02-01
Abstract: A medicament (A) comprises a combination of anticholinergic agent(s) (I) and the corticosteroid ST-126 (II), optionally together with pharmaceutical auxiliaries. ACTIVITY : Antiinflammatory; Antiasthmatic; Antiallergic. MECHANISM OF ACTION : Anticholinergic.
Patent DK-1339750-T3 (DK)
Inventor: GIOVANNONI LEONARDO
IPC: C12N15/09
Filed: 2001-12-06
Granted: 2010-02-15
Abstract: The invention describes a process for filter selection of anti-angiogenesis antibody fragments from a large combinatorial repertoire; the invention further relates to the anti-angiogenesis antibody fragments thus obtained.
Patent DK-1283211-T3 (DK)
Inventor: PAI BALAKRISHNA S
IPC: C07H19/16
Filed: 1995-01-30
Granted: 2006-10-09
Abstract: A method for the treatment of a host, and in particular, a human, infected with HBV or EBV is provided that includes administering an HBV- or EBV- treatment amount of an L-nucleoside of formula (I) <CHEM> wherein R is a purine or pyrimidine base. In one preferred embodiment, the active compound is 2'-fluoro-5-methyl- beta -L-arabinofuranosyluridine (also referred to as L-FMAU) This compound is a potent antiviral agent against HBV and EBV and exhibits low cytotoxicity. Other specific examples of active compounds include N1-(2'-deoxy-2'-fluoro- beta -L-arabinofuranosyl)-5-ethyluracil, N1-(2'-deoxy-2'-fluoro- beta -L-arabinofuranosyl)-5-iodocytosine), and N1-(2'-deoxy-2'-fluoro- beta -L-arabinofuranosyl)-5-iodouracil. <IMAGE>
Patent DK-1277685-T3 (DK)
Inventor: REIST WALTER
IPC: B65H33/16
Filed: 2002-07-08
Granted: 2006-01-23
Abstract: The object path-turning process involves crossing the input path with the output path at two crossing points (A, B), transferring the objects (4) in groups (1A, 1B, 2A, 2B) alternately at the first or second crossing point. The objects lie in overlapped flow sections, and on the output path conveyor, these are gaps (22) between successive groups.
Patent DK-1370127-T3 (DK)
Inventor: MICHEL DAVID
IPC: A01D42/06
Filed: 2002-03-22
Granted: 2008-01-21
Abstract: A chassis for a grass treatment machine on which an elongate grass treatment module having opposed outer ends may be mounted, and in which the chassis is intended to be mounted in, or form part of, the frame of a grass treatment machine. The chassis has two module mountings which are laterally spaced form each other with respect to the direction of travel of the machine, and each mounting being adapted to receive a respective outer end of the module. The chassis has two chassis portions which can be assembled in order to hold the outer ends of the module in the module mountings in order to mount the module on the chassis, and which can be relatively separated in order to provide access to the module mountings for the purposes of mounting or demounting the ends of the module relative to the chassis.
Patent DK-1372766-T3 (DK)
Inventor: VINCENT PATRICE
IPC: A61M5/28
Filed: 2002-03-26
Granted: 2010-05-25
Abstract: A device for dispensing viscoelastic solutions, said device consisting of a syringe ( 1 ) which contains at least two viscoelastic solutions (V 1 , V 2 ) having different properties, said solutions (V 1 , V 2 ) being dispensed in succession, in a predetermined order, said device being characterized in that said syringe ( 1 ) includes at least one moving diaphragm ( 10 ) that separates said at least two viscoelastic solutions (V 1 , V 2 ).
Patent DK-1387630-T3 (DK)
Inventor: LANDA PHILIPPE
IPC: A47B21/00
Filed: 2002-04-10
Granted: 2012-04-23
Abstract: The present invention provides a workstation (1) suitable for acting as a desk or a drawing table for at least one seated user, the workstation comprising a structure (2) supported by a stand (3) so as to be capable of pivoting about a horizontal pivot axis (X), and a window (6) defining a display zone for one or more screens (5) and/or one or more image projector devices disposed beneath the window, said screen(s) and/or said projector device(s) being carried by the structure, each screen and/or each projector device being fixed relative to the portion of the window covering it. The workstation is arranged in such a manner as to enable a seated user to place the legs beneath the structure, at least when the window is horizontal.
Patent DK-1417222-T3 (DK)
Inventor: CARUSO ARNALDO
IPC: A61K38/00
Filed: 2002-08-05
Granted: 2010-12-13
Abstract: New isolated polypeptides of the protein p17 of HIV are described, represented by the formula: NH2-X1-Gly-X2-X3-Leu-Asp-X4-Trp-Glu-X5-Ile-X6-Leu-Arg-COOH (SEQ ID NO:1) in which X1 is an amino acid residue selected from Ser and Arg; X2 is an amino acid residue selected from Gly, Glu and Ser; X3 is an amino acid residue selected from Glu, Lys, Asp and Arg; X4 is an amino acid residue selected from Arg, Ala, Lys, Thr, Ser, Glu, Asp and Gln; X5 is an amino acid residue selected from Lys, Arg and Ser; and X6 is an amino acid residue selected from Arg and Gln. These polypeptides, when administered to a subject, are able to evoke anti-p17 neutralizing antibodies and are therefore useful as vaccine or inoculum. Monoclonal and polycolonal anti-p17 antibodies which are able to neutralize the biological activity of this viral protein and to recognize its neutralization epitope in a specific manner are also described.
Patent DK-1370547-T3 (DK)
Inventor: CASTANT-CUISIAT FLORENCE
IPC: C07C323/22
Filed: 2002-03-20
Granted: 2005-01-17
Abstract: 3-(arylthiopropylamino)-1,5-aryloxathiepine derivatives (I) are new.  3-(arylthiopropylamino)-1,5-aryloxathiepine derivatives of formula (I) and their (hydrated) addition salts with (in)organic acids, tautomers, enantiomers and stereoisomers are new. R1 and R2  = H, fluoro, chloro, hydroxy, 1-3C alkyl, cyclopropyl, cyclopropoxy; or R1 +R2 = 5-membered non-aromatic ring, optionally including an oxygen atom;  R3  = 1-3C alkyl, hydroxy or MeO;  R4  = H or Me; and R5 and R6  = hydrogen, 1-3C alkyl, alkoxy or alkylthio, or alkylamino. Provided that when R4 is Me, the R5 is not alkyl, or OR4 and R5 complete a 5- or 6-membered ring containing at least one oxygen. Independent claims are also included for: (1) Methods for preparing (I);  (2) Intermediate amines of formula (VI);  (3) Method for preparing (I);  (4) Aldehydes of formulae (II) and (V); and  (5) Methods for preparing (II) and (V). R3 = 1-3C alkyl or MeO; and R4 = Me in (II) or methoxymethyl in (V).
Patent DK-1393735-T3 (DK)
Inventor: MELROSE GRAHAM JOHN HAMILTON
IPC: C08L33/00
Filed: 1996-05-30
Granted: 2008-10-06
Abstract: The present invention relates to the treatment of gastrointestinal disease and/or cancer, and a method of weight gain, via the ingestion of polymeric compositions in humans, animals or birds in need of said treatment. The invention provides methods for the treatment of cancer, the treatment and/or prevention of gastrointestinal disease and/or infection and/or diarrhoea, and a method for increasing weight gain in humans, animals or birds comprising administering to said humans, animals or birds an effective amount of a pharmaceutical or veterinary composition or feed additive, comprising an effective amount of a polymer and/or copolymer, having the repeating polymeric unit (I) wherein R is H or alkyl, usually C1 to C4, or this unit in hydrated, hemiacetal or acetal form, together with a pharmaceutically or veterinarally acceptable carrier, diluent, adjuvant, excipient and/or controlled release system. <CHEM>
Patent DK-1541674-T3 (DK)
Inventor: ITO MASASHI
IPC: A61K35/12
Filed: 2003-06-18
Granted: 2011-03-14
Abstract: The present invention relates to primary cultured adipocytes for gene therapy, where the adipocytes stably maintain a foreign gene encoding a protein that is secreted outside of cells. This invention provides cells suitable for gene therapy, which can replace bone marrow cells and liver cells used for conventional  ex vivo  gene therapy. The present invention established methods for transferring foreign genes into primary cultured adipocytes, which are suitable for ex vivo gene therapy; can be easily collected and implanted; and can be removed after implantation. Specifically, the present invention established these methods that use retroviral vectors. The present invention also established primary cultured adipocytes for gene therapy, where the adipocytes stably maintain a foreign gene encoding a protein that is secreted outside of cells.